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Aims Technological limitations have restricted in vivo assessment of intracellular pH (pHi) in the myocardium. The aim of
this study was to evaluate the potential of hyperpolarized [1-
13C]pyruvate, coupled with
13C magnetic resonance
spectroscopy (MRS), to measure pHi in the healthy and diseased heart.
Methods
and results
Hyperpolarized [1-
13C]pyruvate was infused into isolated rat hearts before and immediately after ischaemia, and the
formation of
13CO2 and H
13CO3
2 was monitored using
13C MRS. The HCO3
2/CO2 ratio was used in the Hender-
son–Hasselbalch equation to estimate pHi. We tested the validity of this approach by comparing
13C-based pHi
measurements with
31P MRS measurements of pHi. There was good agreement between the pHi measured using
13C and
31P MRS in control hearts, being 7.12+0.10 and 7.07+0.02, respectively. In reperfused hearts,
13C and
31P measurements of pHi also agreed, although
13C equilibration limited observation of myocardial recovery from
acidosis. In hearts pre-treated with the carbonic anhydrase (CA) inhibitor, 6-ethoxyzolamide, the
13C measurement
underestimated the
31P-measured pHi by 0.80 pH units. Mathematical modelling predicted that the validity of measur-
ing pHi from the H
13CO3
2/
13CO2 ratio depended on CA activity, and may give an incorrect measure of pHi under
conditions in which CA was inhibited, such as in acidosis. Hyperpolarized [1-
13C]pyruvate was also infused into
healthy living rats, where in vivo pHi from the H
13CO3
2/
13CO2 ratio was measured to be 7.20+0.03.
Conclusion Metabolically generated
13CO2 and H
13CO3
2 can be used as a marker of cardiac pHi in vivo, provided that CA activity
is at normal levels.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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1. Introduction
The rapid onset of acidosis is a well-documented characteristic of myo-
cardialischaemia.
1,2Underpoorcoronaryperfusion,anaerobicglycolysis
increasesintheheart,producingintracellularprotonsandlacticacidthat
accumulateintheintra-andextracellularspaces.
3Someoftheacidreacts
withHCO3
2 toformCO2,whichaddstoanyCO2generated byresidual
oxidative metabolism. Accumulation of protons, lactic acid, and CO2 in
the ischaemic heart decreases intracellular pH (pHi)f r o mn o r m a l
levels of around 7.1–7.2.
1,2 Transient acidosis during ischaemia may be
beneﬁcial, as it decreases the major adenosine triphosphate (ATP) con-
sumer, contractility, and thus conserves ATP for ion transport.
4
However, the ATP reduction caused by severe and sustained ischaemia
decreases Na
þ,K
þ-ATPase activity, which increases myocardial Na
þ
levels. Increased Na
þ inhibitsCa
2þ extrusionviatheNa
þ/Ca
2þ exchan-
ger, thus elevating myocardial Ca
2þ and damaging the myocardium.
5
* Corresponding author. Tel: þ44 1865 282249; fax: þ44 1865 282272, Email: marie.schroeder@dpag.ox.ac.uk
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-
commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of
publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.
For commercial re-use, please contact journals.permissions@oxfordjournals.org.
Cardiovascular Research (2010) 86,8 2 – 9 1
doi:10.1093/cvr/cvp39631P magnetic resonance spectroscopy (MRS) has long been the gold
standard for pHi measurement in the isolated perfused heart,
6 based
on the chemical shift of the inorganic phosphate (Pi) peak.
7,8
However,
31P MRS cannot measure cardiac pHi in vivo, because
2,3-diphosphoglycerate (2,3-DPG) in the ventricular blood contami-
nates the myocardial Pi peak.
6,9,10
The pH-dependent equilibrium between bicarbonate and CO2 has
been used to measure extracellular pH (pHo) non-invasively in
tumours.
11 By infusing hyperpolarized
13C-bicarbonate intravenously,
MR was used to image the distribution of hyperpolarized bicarbonate
and CO2 and a pH map was generated using the Henderson–Hassel-
balch equation:
pH ¼ pKa þ log
½HCO3
  
½CO2 

ð1Þ
where pKa is the acid-dissociation constant of CO2, which is 6.15 in
the Krebs–Henseleit buffer.
12
For correct application of the Henderson–Hasselbalch equation,
the following two conditions must be met:
(i)
13CO2 to H
13CO3
2 exchange kinetics, catalysed by carbonic anhy-
drase (CA), must be rapid and
(ii)
13CO2 and H
13CO3
2 signals must be detected simultaneously
from the same cellular compartment.
In tumours, the Henderson–Hasselbalch equation was applied cor-
rectly because of the high CA activity on the surface of tumour
cells
13 and within erythrocytes,
14 and the slow, transporter-mediated,
cellular uptake of infused bicarbonate.
15
A similar approach may be useful for measuring pHi in the in vivo
heart.
16,17 Infusion of hyperpolarized [1-
13C]pyruvate results in mito-
chondrial production of hyperpolarized
13CO2 by pyruvate dehydro-
genase (PDH, Figure 1).
18 Hyperpolarization by the dynamic nuclear
polarization method increases the
13C MR sensitivity of pyruvate,
and other
13C-labelled metabolites, more than 20 000-fold.
19
Further, when a hyperpolarized metabolite is infused into tissue,
the high-sensitivity
13C label is transferred to the tracer’s metabolic
products, enabling unprecedented real-time visualization of the bio-
chemical mechanisms of normal and abnormal metabolism. Only
metabolic processes that occur rapidly can be monitored using hyper-
polarized
13C MR methods because the hyperpolarized signal decays
to thermal equilibrium according to its inherent spin–lattice relax-
ation time (in the case of [1-
13C]pyruvate with a time constant of
50–60 s).
In theory, simultaneous detection of hyperpolarized
[1-
13C]pyruvate-derived
13CO2 and H
13CO3
2 could be used to
measure pHi. However, in cardiac myocytes, the conditions required
for the correct use of the Henderson–Hasselbalch equation may not
apply. As shown in Figure 1, metabolically generated CO2 diffuses
rapidly from its site of production into the cytosol, and subsequently
into the extracellular space.
20 Cardiac myocytes also have HCO3
2
transport activity, through proteins such as the Na
þ–HCO3
2
co-transporter and the Cl
2/HCO3
2 exchanger.
12 Studies of CA local-
ization and kinetics in cardiac myocytes suggest low intracellular CA
activity.
21 Under the acidic conditions, typical of ischaemia, CA activity
is expected to be even lower.
22,23 Further, PDH ﬂux post-ischaemia
must be sufﬁciently high to enable MR detection of
13CO2 and
H
13CO3
2
, prior to decay of the hyperpolarized
13C MR signal.
Figure 1 The metabolic fate of infused hyperpolarized [1-
13C]pyruvate is shown. Infused pyruvate is oxidized to form acetyl-CoA and the
by-product,
13CO2, in the mitochondria, by the enzyme PDH. Mitochondrial
13CO2 is then thought to rapidly diffuse into the cytosol, and sub-
sequently out of the cell. In theory,
13CO2 in either the mitochondria or the cytosol could equilibrate with H
13CO3
2, mediated by CA activity.
Once
13CO2 diffuses into the bloodstream, it will rapidly equilibrate with H
13CO3
2 via CA. CA, carbonic anhydrase; PDH, pyruvate dehydrogenase;
MCT, mono-carboxylate transporter; NHE, sodium proton exchanger; NBC, sodium bicarbonate carrier; CBE, chloride bicarbonate exchanger; NCE,
sodium calcium exchanger.
Measuring cardiac intracellular pH using hyperpolarized metabolites 83The aim of the present study was to evaluate the potential of
hyperpolarized
13C MR for the non-invasive measurement of pHi in
the heart. We measured PDH ﬂux and the production of
13CO2
and H
13CO3
2 in isolated hearts before and after ischaemia and with
CA activity inhibited. We used mathematical modelling to determine
whether, and under what conditions, the H
13CO3
2/
13CO2 ratio could
be used to measure cardiac pHi. Finally, we measured pHi in the in vivo
rat heart.
2. Methods
2.1 The isolated perfused rat heart
All investigations conformed to the Guide for the Care and Use of Lab-
oratory Animals published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996), the Home Ofﬁce Guidance on
the Operation of the Animals (Scientiﬁc Procedures) Act, 1986
(HMSO), and to institutional guidelines. Male Wistar rats (300 g)
were anaesthetized using a 0.7 mL ip injection of pentobarbital sodium
(200 mg/mL Euthatal). The beating hearts were quickly removed and
arrested in the ice-cold Krebs–Henseleit perfusion buffer, and the aorta
was cannulated for perfusion in recirculating retrograde Langendorff
mode at a constant 85 mmHg pressure and 378C temperature.
24 The
Krebs–Henseleit bicarbonate perfusion buffer contained 1.2 mM inor-
ganic phosphate (KH2PO4), 11 mM glucose, and 2.5 mM pyruvate and
was aerated with a mixture of 95% oxygen (O2) and 5% carbon dioxide
(CO2) to give a ﬁnal pH of 7.4 at 378C. The broad-spectrum CA inhibitor,
6-ethoxyzolamide (ETZ), was dissolved in dimethyl sulfoxide (DMSO) and
added to the perfusate to achieve a ﬁnal concentration of 100 mM (with
DMSO , 0.01% of total buffer volume). ETZ was expected to evenly dis-
tribute throughout the intra- and extracellular spaces to inhibit all cardiac
CA isoforms.
20 Unless speciﬁed, compounds were obtained from Sigma
(Gillingham, UK). For further details of the Langendorff heart perfusion
method, see Supplementary material online, S1.
2.2 Experimental protocols
2.2.1 Control protocol
Isolated hearts (n ¼ 6) were perfused for 30 min at 85 mmHg. For the
initial 20 min,
31P MRS was used to measure pHi. After this, hyperpol-
arized [1-
13C]pyruvate was infused and the progress of
13C-labelled com-
pounds was followed using
13C MRS.
2.2.2 Inhibition of CA
Hearts (n ¼ 5) were perfused for 30 min. After 10 min of perfusion in
normal buffer, the hearts were switched to buffer containing 100 mM
ETZ.
31P MRS was performed for 20 min (10 min before and 10 min
after switch over to ETZ-containing buffer). Ten minutes after the start
of ETZ perfusion, hyperpolarized [1-
13C]pyruvate was infused and MRS
was switched from
31Pt o
13C.
2.2.3 Reperfusion following ischaemia
Hearts (n ¼ 12) were perfused for 30 min, followed by 10 min of total,
global ischaemia, and 15 min reperfusion.
31P MRS spectra were acquired
for 20 min immediately before and 9 min during ischaemia. Hyperpol-
arized [1-
13C]pyruvate was infused immediately after ischaemia, such
that hearts were reperfused with hyperpolarized tracer. In some hearts
(n ¼ 6),
31P MRS was performed throughout the reperfusion period. In
other hearts (n ¼ 6),
13C MRS was performed for 2 min during initial
reperfusion with hyperpolarized [1-
13C]pyruvate, followed by 10 min of
31P MR spectral acquisition. For details of the [1-
13C]pyruvate preparation
and delivery, see Supplementary material online, S2.
2.3 Magnetic resonance spectroscopy
31P MR spectra were acquired at 202.5 MHz using a 308 radiofrequency
(RF) pulse and a repetition delay of 0.25 s. The phosphocreatine (PCr)
resonance was set at 0 ppm and the chemical shifts of all peaks were
referenced to that of PCr. Each spectrum consisted of 120 transients,
giving a total acquisition time of 30 s. As these partially saturated
spectra had shorter repetition times than the longitudinal relaxation
time of
31P nuclei, an unsaturated spectrum was initially acquired from
the hearts using a 908 pulse with repetition time of 15 s and 40 transients,
and an acquisition time of 10 min. The unsaturated spectra were used to
correct metabolite concentrations for the effects of saturation.
Acquisition of
13C MR spectra commenced immediately after infusion of
hyperpolarized [1-
13C]pyruvate and [1-
13C]pyruvate infusion continued
throughoutacquisition.Spectrawereacquiredwith1 stemporalresolution
over 2 min (excitation ﬂip angle ¼ 308, 120 acquisitions). Spectra were
centred at 150 ppm and referenced to the [1-
13C]pyruvate resonance at
171 ppm, and 4096 points were acquired over a bandwidth of 100 ppm.
In vivo hyperpolarized [1-
13C]pyruvate MRS experiments were per-
formed as described previously.
18 Brieﬂy, [1-
13C]pyruvic acid was hyper-
polarized and dissolved/neutralized in a prototype
13C polariser system.
25
Each living rat (n ¼ 6) was positioned at the isocentre of a 7 T Varian hori-
zontal bore MR scanner, with a dual-tuned
1H/
13C coil localized over the
animal’s chest. Aqueous hyperpolarized [1-
13C]pyruvate (80 mmol) was
then infused into a living rat via the tail vein over 10 s, and cardiac
13C
spectra were acquired with a low 7.58 ﬂip angle every second for 1 min.
For further details of in vivo hyperpolarized [1-
13C]pyruvate MRS exper-
iments, refer to Supplementary material online, S3.
2.4 Data analysis
2.4.1 Carbon-13
Cardiac
13C MR spectra were analysed using the AMARES algorithm, as
implementedinthejMRUIsoftwarepackage.
26SpectrawereDCoffsetcor-
rectedbasedonthelasthalfofacquiredpointsandpeakscorrespondingwith
[1-
13C]pyruvateanditsmetabolicderivativeswereﬁttedassumingaLorent-
zian line shape, initial peak frequencies, relative phases, and linewidths.
Forspectraacquiredfromperfusedrathearts,themaximumpeakareaof
each metabolite over the 2 min of acquisition was determined for each
series of spectra and expressed as a percentage of the maximum
[1-
13C]pyruvateresonance.
18Therateofsignalproductionforeachmetab-
olite, in percent per second (%/s), was measured as the slope of the mean
metabolite increase over the ﬁrst 5 s following its appearance, over which
time the metabolite signal increased linearly. Additionally, a ﬁrst-order
exponential signal decay term was ﬁt to each metabolite peak from the
point of maximum signal over the course of signal decay. Decay of the
hyperpolarized signal depends on the intrinsic spin–lattice relaxation of
the nucleus, production and consumption rates of the metabolite, and
metabolite washout, and may therefore provide information about metab-
olite accumulation in the states of no-ﬂow ischaemia and CA inhibition.
Average time courses for H
13CO3
2,
13CO2, and their sum were calcu-
lated for all hearts for further data analysis. H
13CO3
2 plus
13CO2, normal-
ized to the maximum pyruvate peak area to allow for any differences in
polarization, was used as a qualitative indicator of PDH ﬂux. The
average H
13CO3
2 and
13CO2 time courses were inserted into an
applied form of the Henderson–Hasselbalch equation:
pR ¼ 6:15 þ log
½H13CO3
  
½
13CO2 

ð2Þ
The output of Eq. (2) is a variable pR which should, under the two con-
ditions outlined in Section 1, measure pH. Upon the initial arrival of
[1-
13C]pyruvate, the relative proportions of
13CO2 and H
13CO3
2 (and
thus pR) equilibrated over several seconds to reach a
M.A. Schroeder et al. 84steady-state value. The calculated pR was ﬁt to a ﬁrst-order exponential
equation to determine the steady-state value and time constant.
2.4.2 Phosphorus-31
Cardiac
31P MR spectra were analysed using the AMARES algorithm in the
jMRUI software package.
26 Spectra were corrected for DC offset using the
last half of acquired points. The PCr, Pi, a-, b-, and g-ATP resonances were
ﬁtted assuming a Lorentzian line shape, peak frequencies, relative phases,
linewidths,andJ-couplingparameters.pHiwascalculatedfromthePichemi-
cal shift.
8,27 Absolute
31P metabolite concentrations were calculated using
an ATP concentration of 10.6 mM from the ﬁrst g-ATP peak area
28 and
expressing all other ATP and PCr peak areas relative to this area.
27
2.4.3 Modelling
A system of ordinary differential equations was formulated to test the suit-
ability of using the CO2–HCO3
2 equilibrium to measure pHi. For details of
the mathematical model, see Supplementary material online, S4.
2.4.4 Statistical methods
Data are given as mean+standard error. Statistical signiﬁcances between
pre- and post-ischaemic groups, and pre-ischaemic and ETZ-perfused
groups, were assessed using a paired Student’s t-test. Statistical signiﬁ-
cance was considered at P , 0.05.
3. Results
3.1 Myocardial energetics
Cardiac function and
31P MR spectra were characteristic of the iso-
lated rat heart during pre-ischaemia, ischaemia, and reperfusion.
1 A
description of cardiac function throughout the protocol and an
example of a
31P spectrum of a heart before ischaemia are shown
in Supplementary material online, S5. Pre-ischaemia, the average
[ATP] was 10.6+0.7 mM and [PCr] was 19.7+0.9 mM (Figure 2).
Two minutes after stopping coronary ﬂow, [PCr] decreased to
3.2 mM, to remain at 1.1–2.1 mM for the remainder of ischaemia.
The rate of [ATP] hydrolysis during ischaemia was 0.14+0.10 mM/
min. Five minutes after reperfusion, PCr had recovered to 17.6+
1.9 mM, whereas ATP remained at 8.2+2.5 mM.
Perfusion with ETZ had no effect on [ATP] or [PCr] throughout
the perfusion protocol (data not shown). Prior to ETZ perfusion,
hearts had an average PCr of 17.8+1.9 mM and ATP of 10.6+
0.5 mM. During ETZ perfusion, the average [PCr] was 18.0+
1.5 mM and [ATP] was 10.3+0.9 mM.
3.2 PDH ﬂux
A representative spectrum of [1-
13C]pyruvate in the perfused heart,
and the typical kinetic progression of [1-
13C]pyruvate metabolites,
is shown in Figure 3. Following infusion of [1-
13C]pyruvate into
control hearts, [1-
13C]lactate (183.2 ppm), H
13CO3
2 (160.9 ppm),
and [1-
13C]alanine (176.5 ppm) were clearly detectable with high
signal compared with the baseline. A resonance corresponding to
13CO2 was also visible, with 1 s temporal resolution, at a chemical
shift of 124.5 ppm. The initial rates of production and the maximum
peak areas for the [1-
13C]pyruvate-derived metabolites, in pre-
ischaemic, ETZ, and reperfused hearts, are given in Table 1.
The maximum peak areas of H
13CO3
2,
13CO2, and their sum were
not signiﬁcantly different from baseline when [1-
13C]pyruvate was
infused into the myocardium upon reperfusion. However, the initial
rateofH
13CO3
2 plus
13CO2productionwas54%sloweruponreperfu-
sion,comparedwiththepre-ischaemicmyocardium,asindicatedbythe
slopeofthereperfusionpeaksshowninFigure4.Additionally,thedecay
rateofhyperpolarized
13CO2signalwas30%fasterinreperfusedhearts
than in pre-ischaemic hearts (P , 0.001), indicating enhanced CO2
washout upon re-ﬂow after ischaemia.
ETZ had no signiﬁcant effect on the initial rate of H
13CO3
2 plus
13CO2 production, or the maximum peak area of the sum of
H
13CO3
2 and
13CO2, compared with pre-ischaemic hearts
(Figure 4). However, ETZ increased the maximum
13CO2 peak area
by four-fold, whereas decreasing the maximum H
13CO3
2 peak area
by two-fold (Table 1, P , 0.001). Additionally, the decay rate of hyper-
polarized
13CO2 signal was 19% faster in reperfused hearts than in
pre-ischaemic hearts (P , 0.05), possibly indicating enhanced CO2 dif-
fusion out of myocytes in the absence of CA activity.
3.3 Measurement of pHi in the isolated
perfused heart
Figure 5A shows the changes in H
13CO3
2 and
13CO2, both normalized
to the maximum [1-
13C]pyruvate signal, which were used for the
Figure 2 Changes in ATP, PCr, Pi, and pHi, before, during, and
after ischaemia. ATP levels gradually decreased during ischaemia,
and after reperfusion, partially recovered to pre-ischaemia levels.
PCr levels rapidly decreased at the onset of ischaemia and rapidly
recovered to pre-ischaemic levels after reperfusion. Pi levels
rapidly increased at the onset of ischaemia and rapidly decreased
to pre-ischaemic levels after reperfusion. pHi gradually decreased
from 7.07 to 6.49 during ischaemia and rapidly recovered to pre-
ischaemia levels following reperfusion.
Measuring cardiac intracellular pH using hyperpolarized metabolites 85calculation of pR. When hyperpolarized [1-
13C]pyruvate reached the
isolated heart, metabolically generated H
13CO3
2 and
13CO2 were out
of equilibrium for 5 s before pR [Eq. (2)] reached a steady-state
value of 7.12+0.10 (Figure 5B). Fully relaxed
31P measurements,
acquired in the pre-ischaemic heart, gave a pHi of 7.07+0.02. The
pHi measured using
31P MRS and the 95% conﬁdence interval are
overlaid on the
13C results in Figure 5B.
31P MRS conﬁrmed that CA inhibition with ETZ had no effect on
steady-state myocardial pHi (pHi of 7.02+0.03 before ETZ treat-
ment and 7.00+0.04 after ETZ treatment). Perfusion with
[1-
13C]pyruvate and ETZ generated more
13CO2 than H
13CO3
2
(Figure 5C) with no change in total H
13CO3
2 plus
13CO2. The pR, cal-
culated from the H
13CO3
2/CO2 ratio, stabilized within 20 s to a
steady-state pR of 6.21+0.13 (Figure 5D). Thus, inhibition of CA
activity slowed CO2–HCO3
2 conversion, as shown by the lengthening
of the out-of-equilibrium period, but also by the steady-state pR
which was 0.79 pH units below the pHi measured using
31P MRS.
In reperfused hearts,
31P MRS revealed that pHi recovered from a
value of 6.49+0.04 at the end of ischaemia to 7.04+0.13, at a rate
of 0.73 pH units/min during the 45 s immediately after reﬂow
(Figure 6). In hearts reperfused with hyperpolarized [1-
13C]pyruvate,
the pR from the H
13CO3
2/CO2 ratio was the same as pHi from
31P
MRS after 15 s of reperfusion, when averaged into 30 s segments
that corresponded with acquisition of
31P spectra. After 45 and
75 s, both
13C and
31P measurements gave almost identical pHi
measurements (
13C: 7.01+0.01 at 45 s and 6.98+0.02 at 75 s;
31P: 7.04+0.13 at 45 s and 7.00+0.04 at 75 s, Figure 6).
3.4 Mathematical modelling of
experimental results
Results of the mathematical model of
13CO2 production, efﬂux, and
hydration to H
13CO3
2 by CA are depicted in Figure 7. Figure 7A
shows the output of the model that best-ﬁts the experimental data
presented in Figure 5. Constants KCO2 (10
26.15 M), kf (0.14 s
21), and
kr (kf/KCO2) were obtained from published values
21 and other par-
ameters were obtained by least-squares ﬁtting: Ppyr (0.2 s
21), PCO2
(0.2 s
21), r (0.006 s
21), a (1/33 s for pyruvate, 1/6 s for CO2 and
HCO3
2). The best simulation of our experimental
13CO2 and
H
13CO3
2 results (Figure 7A) indicated that CA activity (g) enhanced
the conversion rate of
13CO2 into H
þ þ H
13CO3
2 by 10-fold in pre-
ischaemic hearts. This value was in line with an in vitro study that
reported CA-enhanced CO2 hydration by ﬁve-fold in isolated
myocytes.
21
Figure 7B shows the value of pR [Eq. (2)] derived from the simu-
lations in Figure 7A. At normal CA activity (g ¼ 10), pR approached
6.8 within 17 s, giving a reasonable approximation to the real pHi of
7.1. However, in the absence of CA activity (g ¼ 1), pR approached
a signiﬁcantly lower asymptote of 6.1 within 24 s.
Apart from CA activity, another factor that can disturb the equili-
brium between H
þ, HCO3
2 and CO2 is HCO3
2 transport. Figure 7C
and D illustrates the implications of HCO3
2 extrusion and uptake,
respectively, on the steady-state value of pR. In the presence of
+5 mM/min transmembrane HCO3
2 ﬂux, the value of pR was not
greatly altered, compared with a model with no net HCO3
2 transport.
Figure 3 (A) Representative spectrum acquired during hyperpolarized [1-
13C]pyruvate infusion into the isolated perfused heart. Five single 1 s
spectra were summed to yield this spectrum, acquired using a 308 RF pulse. (B) Changes in the metabolic products of [1-
13C]pyruvate in pre-ischaemic
hearts (n ¼ 6).
M.A. Schroeder et al. 86It is noteworthy that hyperpolarized H
13CO3
2 is only a small fraction
of total HCO3
2, and only a minor fraction of transmembrane HCO3
2
efﬂux would be labelled with hyperpolarized
13C.
Further modelling explored the relationship between pHi and the
steady-state pR (Figure 7E) and the time required for equilibration
(Figure 7F), measuredasthe time taken for pR to approach steady-state
pR within 0.05 U. As CA activity (g) was increased, steady-state pR
approached the true pHi and did so with a smaller time delay. For
low values of CA (g , 10), pR signiﬁcantly underestimated pHi. More-
over,forvaluesofCA , 10,thetimetakenforpRtoattainsteadystate
was10–20 s,asigniﬁcantfractionofthelife-timeofhyperpolarized
13C
compounds
25 and the time of pHi recovery following ischaemia.
3.5 Measurement of pHi in vivo
A representative spectrum of [1-
13C]pyruvate infused in vivo is shown
in Figure 8A. The H
13CO3
2 was observed with a signal-to-noise ratio
(SNR) of 9.6+1.1, whereas the
13CO2 peak had an SNR of 1.2+
0.1 and was thus at the limit of detectable signal. Therefore, to calcu-
late pR, 1 s in vivo spectra were averaged in groups of two to yield a
set of spectra with 2 s temporal resolution and the SNR improved to
16.9+3.5 and 2.0+0.4 for H
13CO3
2 and
13CO2, respectively. Using
the averaged spectra, pR reached a steady-state value of 7.20+0.03,
as shown in Figure 8B.
4. Discussion
4.1 PDH ﬂux before and after ischaemia
To study the CO2/HCO3
2 equilibrium, PDH ﬂux must be sufﬁcient to
generate MR-detectable levels of
13CO2. Therefore, our ﬁrst aim was
to determine the effect of ischaemia on pyruvate oxidation. Others
have studied PDH ﬂux upon reperfusion of the ischaemic myocar-
dium, with diverse results depending on the ischaemic model and
the perfusion conditions.
17,24,29–31 Kobayashi and Neely
29 observed
that pyruvate plus glucose perfusion largely maintained PDH activity
in the isolated reperfused heart, and in vivo PDH activity was main-
tained following reduction of coronary ﬂow in swine.
32 However, in
the isolated rat heart perfused with pyruvate alone or pyruvate and
fatty acids, ischaemia decreased PDH activity and glucose oxidation
for several minutes following reperfusion.
17,30,31
Here, 10 min of total global ischaemia decreased the rate of pro-
duction of H
13CO3
2 plus
13CO2 from 0.57+0.06 to 0.26+0.05%/s,
indicating a decrease in the initial rate of pyruvate oxidation, and thus
inhibition of PDH activity in reperfusion. However, a signiﬁcant
decrease in the total H
13CO3
2 and
13CO2 produced was not observed,
suggesting that PDH ﬂux recovered to control levels within 30 s. Most
importantly, sufﬁcient
13CO2 was produced at the start of reperfusion
to allow the H
13CO3
2/
13CO2 ratio to be measured, which, under
appropriate conditions, may be used to estimate pHi.
4.2 CO2/HCO3
2 equilibrium as a measure of
cardiac pHi
We converted the H
13CO3
2/
13CO2 ratio in the isolated perfused rat
heart, and in the in vivo rat heart, into a variable, pR, using the
Henderson–Hasselbalch equation. At steady-state, pR in the isolated
perfused rat heart was 7.12+0.1, similar, within the noise inherent in
................................................................ ................................................................
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Table 1 Metabolite levels and kinetic parameters from
13C MR spectra in pre-ischaemia, reperfused, and ETZ-perfused
isolated hearts
[1-
13C]Lactate [1-
13C]Alanine
Pre-ischaemia Reperfusion ETZ Pre-ischaemia Reperfusion ETZ
Maximum metabolite/pyruvate (%) 6+13 1 +3
† 7+2 4.2+0.3 3.5+0.2 5.7+0.4
Initial production rate (%/s) 0.7+0.1 4.4+0.4
† 0.7+0.2 0.43+0.09 0.28+0.03 0.7+0.01
Decay, t (s) 35+4 22.3+0.2* 41+53 9 +24 1 +14 3 +7
H
13CO3
2 13CO2
Pre-ischaemia Reperfusion ETZ Pre-ischaemia Reperfusion ETZ
Maximum metabolite/pyruvate (%) 4.7+0.6 3.8+0.4 2.1+0.2* 0.60+0.06 0.70+0.06 2.6+0.2
†
Initial production rate (%/s) 0.49+0.06 0.21+0.04* 0.14+0.02* 0.06+0.02 0.053+0.007 0.31+0.03
†
Decay, t (s) 43+43 5 +24 4 +44 8 +23 3 +2
† 39+3*
Data are expressed means+SEM. All metabolite levels, and initial production rates, are expressed as a percentage of maximum [1-
13C]pyruvate signal.
Signiﬁcant difference from pre-ischaemic hearts: *P , 0.05 and
†P , 0.001.
Figure 4 Comparison of the time courses for the sum of the
bicarbonate and carbon dioxide peaks, normalized to the
maximum value of pyruvate peak area. The maximum peak area
did not change following either intervention, compared with the
control. Following ischaemia, the initial slope of the curve was signiﬁ-
cantly reduced.
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31P
MRS. When measured in rat hearts in vivo, pR was 7.20+0.03.
These values are similar to those of Merritt et al.,
17 and with pHi
measured by others using
31P MRS.
8–10,20,28 Thus, hyperpolarized
[1-
13C]pyruvate can be used to obtain an accurate, non-invasive
measurement of cardiac pHi in vivo in healthy hearts.
17
As a ﬁrst test of the suitability of pR to measure pHi, we inhibited
cardiac CA activity in perfused rat hearts, without altering pHi.W e
found a signiﬁcant difference between the steady-state pR of 6.21
and the pHi of 7.01 determined using
31PM R S .L o wp H i, such as that
observed during myocardial ischaemia, inhibits CA activity.
22,23 Thus,
the H
13CO3
2/
13CO2 ratio would not be a good measure of pHi in
the ischaemic/reperfused heart without correction for low CA activity.
By modelling our H
13CO3
2 and
13CO2 results, we identiﬁed the
conditions in which pR was not a valid measure of pHi. Provided
that sufﬁcient
13CO2 is generated via PDH ﬂux, factors that alter
the rate of CO2 production (Ppyr, r) will not alter steady-state pR.
Likewise, CO2 efﬂux (PCO2) does not affect steady-state pR when
the heart is perfused to the extent that extracellular
13CO2 is
washed away rapidly. Changes to CO2 permeability will alter CO2
and HCO3
2 levels in parallel and will not affect steady-state pR.
A discrepancy between pR and pH occurred with changes in the
rate of CO2 hydration and events related to HCO3
2 and H
þ. The
Figure 5 (A) The bicarbonate and carbon dioxide, both normalized to maximum pyruvate peak area, vs. time in control hearts (n ¼ 6). The
point-by-point ratio of these species was used to calculate pR. (B) Measurement of pR based on H
13CO3
2/
13CO2 in control hearts compared
with measurement of pHi using
31P MRS in the same group of hearts. (C) The bicarbonate and carbon dioxide, both normalized to maximum pyruvate
peak area, in hearts perfused with the CA inhibitor ETZ (n ¼ 5). (D) Measurement of pR based on H
13CO3
2/
13CO2 in ETZ-perfused hearts compared
with measurement of pHi using
31P MRS in the same group of hearts. The steady-state pR approached 6.21, a value which underestimated the true pHi
of the heart by 0.80 pH units.
Figure 6 Comparison of the pR measurements made in reper-
fused hearts using the H
13CO3
2/
13CO2 ratio and the pHi measure-
ments made using
31P MRS. The x-axis shows the time after
reperfusion with hyperpolarized [1-
13C]pyruvate. The
31P measure-
ment at t ¼ 0 equals the pHi following 10 min of simulated ischaemia.
Each pR measurement was calculated as the average of 30 s of
spectra, acquired 15 s before and after the equivalent
31P measure-
ment to allow for direct comparison.
M.A. Schroeder et al. 88rate of CO2 hydration depends on CA activity. CA activity in cardiac
myocytes is modest
21 and, furthermore, CA is inhibited by low
pHi
22,23 and by pharmacological membrane-transport inhibitors.
33
Consequently, CO2 hydration kinetics have an impact on the suit-
ability of pR as a measure of pHi. The importance of CA activity
was tested using a mathematical model (Figure 7). At low CA activity,
pR attained a steady-state that could be very different from pHi, and
the equilibration time could be a signiﬁcant fraction of the lifetime of
hyperpolarized
13C or of recovery from ischaemia-induced acidosis.
Membrane transport of H
þ and HCO3
2, being down-stream of CO2
hydration, also displaced pR away from pHi. Because of high pHi buffer-
ing capacity inside myocytes,
2 transport of HCO3
2 would have a rela-
tively greater effect on the state of the CO2/HCO3
2 equilibrium than
H
þ transport. The mathematical model was used to investigate
HCO3
2 transport at the modest rate of +5m M / m i n( Figure 7C and
D). The error due to HCO3
2 transport was, however, negligible and
is therefore too slow to signiﬁcantly affect CO2/HCO3
2 equilibrium.
4.3 Limitations of the study
To measure pHi using [1-
13C]pyruvate, it is essential that the metabo-
lically generated H
13CO3
2 and
13CO2 resonances can be accurately
quantiﬁed above the baseline noise. At a physiological pH of 7,
the H
13CO3
2 resonance is 10-fold larger than the
13CO2 resonance,
so
13CO2 quantiﬁcation requires efﬁcient hyperpolarization, high
PDH ﬂux, and careful data acquisition. An increase in achievable
polarization, from the 30% observed here to 60%, has recently
been reported
19 and will aid
13CO2 quantiﬁcation. Also, strategic
data acquisition after the
13C equilibration period, over a shorter dur-
ation, and with a higher excitation ﬂip angle may further increase the
13CO2 signal.
Figure 7 The results of mathematically modelling our experimental data, acquired from control hearts and hearts perfused with ETZ. (A) Results
from the model which best-ﬁt our experimental data from Figures 4A and 5A. Experimental data were best reproduced with a 10-fold catalytic activity
of CA. (B) The model simulation of pR, based on the time courses from (A). With moderate levels of CA activity, as may be expected in the heart, the
H
13CO3
2/
13CO2 ratio indicates a steady-state pR that closely approximates the physiological values. However, with lower CA activity, the model
reproduced our experimental ﬁnding of pHi underestimation. (C) The relationship between CA activity and steady-state pR, in the presence
(dashed grey) and absence (black solid) of HCO3
2 efﬂux or (D) inﬂux. CA activity has a signiﬁcant effect on the size of the pR–pHi discrepancy,
but HCO3
2 transport has a much smaller impact on the discordance. (E) Relationship between steady-state pR and pHi, simulated for different
levels of CA activity. (F) Relationship between equilibration time and pHi, simulated for different levels of CA activity. Equilibration time was estimated
as the time taken for pR to approach steady-state pR within 0.05 U.
Measuring cardiac intracellular pH using hyperpolarized metabolites 89A second limitation of this study is the fact that the hyperpolarized
label cannot directly distinguish between metabolites located in the
intra- and extracellular spaces. We can be certain that due to high
cardiac oxidative rates, which are more than an order of magnitude
higher than any neighbouring tissue (i.e. liver, resting skeletal
muscle, adipose tissue, diaphragm, or blood), virtually all of the
detected H
13CO3
2 and
13CO2 signal was produced within the myo-
cardium. However, it is possible that trace amounts of
13CO2 may
have diffused out of the myocardium and were subsequently hydrated
to form H
13CO3
2 either spontaneously, by extracellular cardiac CA,
or in vivo, by CA in red cells. However, we believe that the contri-
bution of the extracellular H
13CO3
2 and
13CO2 signal to our pHi
measurement was small because: (i) in vivo spectroscopic
13C
images acquired of the heart
34 have indicated that H
13CO3
2 is con-
ﬁned to the myocardium, a region dominated by the intracellular
space; (ii) in the perfused heart, high coronary ﬂow rates (20 mL/
min) would have rapidly removed hyperpolarized metabolites, and
in vivo association of
13CO2 with haemoglobin would have caused
rapid decay of hyperpolarized MR signal; and (iii) the close agreement
between pR measured with
13C and pHi measured with
31P in the
perfused heart indicated minimal contamination from extracellular
H
13CO3
2 and
13CO2, as these species would have equilibrated accord-
ing the pHo of 7.4.
4.4 Signiﬁcance of this work
Currently, the non-invasive measurement of cardiac pHi in humans is
impossible, because blood 2,3-DPG signal overlies the myocardial Pi
signal.
6,9,10 Here, we have shown that in the presence of endogenous
CA activity, the H
13CO3
2/
13CO2 ratio accurately measured pHi in the
isolated perfused heart. Further, we have demonstrated that following
infusion of hyperpolarized [1-
13C]pyruvate into healthy rats in vivo, the
MR signal corresponding to H
13CO3
2 and
13CO2 could both be quan-
tiﬁed, and that their ratio indicated a pHi value of 7.20, which is in line
with invasive measurements.
9,10 Consequently, it seems that meta-
bolically generated H
13CO3
2 and
13CO2 may offer the ﬁrst technique
for the non-invasive measurement of pHi in normal hearts, and in dis-
eased hearts with normal or elevated CA activity.
35 Measuring in vivo
pHi also implies that other analyses of myocardial energetics may be
performed in vivo, including calculation of free ADP concentrations
and the free energy available from the hydrolysis of ATP, DGATP.
5,10
Future work will involve correlating in vivo measurements of the
H
13CO3
2/
13CO2 ratio with pHi measurements made using invasive,
blood-removed or open-chest techniques.
9,10
Since acidosis is a characteristic feature of ischaemia, assessment of
ischaemic heart disease in humans is another potentially useful appli-
cation of a non-invasive pHi calculation using the H
13CO3
2/
13CO2
ratio. We observed excellent agreement between pHi measured
using
31P MRS and pR measured using
13C MRS in the reperfused
myocardium when pHi was  6.74 (Figure 6). However, multiple
factors shift pR relative to pHi, including inhibition of CA activity at
low pHi
22,23 and stimulation of membrane transport during reperfu-
sion following ischaemia.
2,36 Pharmaceutical agents, such as cariporide,
inhibit membrane ion transport and have been used clinically to
reduce ischaemia–reperfusion injury,
37 but also block CA.
33 There-
fore, the use of the H
13CO3
2/
13CO2 ratio to measure pHi may not
be valid in ischaemic, acidic hearts, and in patients with ischaemic
heart disease who use drugs that inhibit membrane ion transport.
Additionally, it is reasonable to expect that intracellular CA
expression and activity may be either reduced or increased in other
forms of cardiomyopathy.
35 Correction of pR to pHi will require
Figure 8 (A) Representative in vivo spectrum acquired during hyperpolarized [1-
13C]pyruvate infusion into living rat hearts. Two single 1 s spectra
were summed to yield this spectrum, acquired using a 308 RF pulse. (B) Measurement of in vivo pR based on H
13CO3
2/
13CO2 in living rat hearts.
M.A. Schroeder et al. 90full characterization of CA activity in each pathophysiological state,
and mathematical deconvolution of the
13C equilibration period
from the true measured pHi changes.
Eventual translation of the H
13CO3
2/
13CO2 ratio to measure pHi in
the clinic will require considerable technological advances, in terms of
improved methods and hardware for acquisition of
13C images, and
access to affordable hyperpolarization tools and
13C-labelled com-
pounds. In order to identify focal regions of ischaemia using pHi
measurements from hyperpolarized [1-
13C]pyruvate, for example,
three-dimensional images of H
13CO3
2 and
13CO2 with relatively
high spatial resolution across the area at risk will be required. The
feasibility of acquiring such data across the myocardium of large
animals, and therefore patients, has been demonstrated.
34 Further,
although the eventual cost of clinical application of the hyperpolarized
13C MR technology is not clear, it does not appear set to be prohibi-
tive. Clinical polarizers could be operated as standalone systems,
placed within existing clinical MR facilities and interfaced to existing
MR scanners. Further, the cost of [1-
13C]pyruvic acid, as used here,
is not excessive and would be in line with contrast agents used in
other imaging modalities, such as positron emission tomography.
In summary, we have demonstrated in the perfused heart that the
H
13CO3
2/
13CO2 ratio offers an accurate method to measure cardiac
pHi in hearts with normal or elevated CA activity. Further, the tech-
nique appears set to become the ﬁrst clinically relevant measure of in
vivo cardiac pHi, although future work is warranted to characterize CA
activity and the response of the H
13CO3
2/
13CO2 ratio in ischaemia
and other cardiomyopathies, and to improve the sensitivity and
spatial resolution of H
13CO3
2 and
13CO2 detection.
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